For the latest updates on our ongoing response to COVID-19, please click here.



Gilead’s manufacturing facility in Edmonton, located in the Canadian province of Alberta, handles development and manufacturing of investigational drugs, supplies active pharmaceutical ingredients for clinical research programs and contributes to new product launch supplies.

Gilead’s Alberta facility is committed to the development and manufacture of life-saving medicines without adversely affecting the health and safety of its employees, its neighbors, or its environment. For more information about Gilead Alberta’s Environmental Policy, click here.

Contact Information

Gilead Alberta ULC

1021 Hayter Road

Edmonton, Alberta

T6S 1A1

Phone: +1 780-701-6400 +1 780-701-6400

Fax: +1 780-472-8189


Gilead’s office in Mississauga, located in the Canadian province of Ontario, provides Administrative, Commercial, Medical, Regulatory, Finance and Legal support for Biktarvy®, Cayston®, Hepsera®, Viread®, Truvada®, Atripla®, Complera®, Stribild®, Sovaldi®, Descovy®, Epclusa™, Genvoya®, Harvoni®, Odefsey™, Vemlidy™ and Zydelig® in Canada.

Voluntary Disclosure of Payments
Divulgation volontaire des paiements

Gilead Sciences Canada, Inc. included in Forbes Canada’s Most Reputable Companies 2017

Contact Information

Gilead Sciences Canada, Inc.

6711 Mississauga Road

Suite 600

Mississauga, Ontario

L5N 2W3

Phone: +1 905-363-8008 +1 905-363-8008

Fax: +1 905-363-8019

Canada Medical Information

Phone:  1-905-363-8009 or 1-866-207-4267